| … . | Total (N = 79) . | Cannabidiol (N = 39) . | Placebo (N = 40) . | P Value . |
|---|---|---|---|---|
| Total number of adverse effects | 109 | 56 | 53 | .740a |
| Number of participants experiencing at least 1 adverse effect | 56 | 28 | 28 | 1.00b |
| Total number of treatment-related adverse effects | 15 | 7 | 8 | .616a |
| Adverse effects-related withdrawal | 5 | 3 | 2 | .625a |
| … . | Total (N = 79) . | Cannabidiol (N = 39) . | Placebo (N = 40) . | P Value . |
|---|---|---|---|---|
| Total number of adverse effects | 109 | 56 | 53 | .740a |
| Number of participants experiencing at least 1 adverse effect | 56 | 28 | 28 | 1.00b |
| Total number of treatment-related adverse effects | 15 | 7 | 8 | .616a |
| Adverse effects-related withdrawal | 5 | 3 | 2 | .625a |
aWilcoxon-Mann-Whitney test.
bBinomial test.
| … . | Total (N = 79) . | Cannabidiol (N = 39) . | Placebo (N = 40) . | P Value . |
|---|---|---|---|---|
| Total number of adverse effects | 109 | 56 | 53 | .740a |
| Number of participants experiencing at least 1 adverse effect | 56 | 28 | 28 | 1.00b |
| Total number of treatment-related adverse effects | 15 | 7 | 8 | .616a |
| Adverse effects-related withdrawal | 5 | 3 | 2 | .625a |
| … . | Total (N = 79) . | Cannabidiol (N = 39) . | Placebo (N = 40) . | P Value . |
|---|---|---|---|---|
| Total number of adverse effects | 109 | 56 | 53 | .740a |
| Number of participants experiencing at least 1 adverse effect | 56 | 28 | 28 | 1.00b |
| Total number of treatment-related adverse effects | 15 | 7 | 8 | .616a |
| Adverse effects-related withdrawal | 5 | 3 | 2 | .625a |
aWilcoxon-Mann-Whitney test.
bBinomial test.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
